ArticleInvestigational new drugs2022

ZL-n-91, a specific Phosphodiesterase-4 inhibitor, suppresses the growth of triple-negative breast cancer.

Longming Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.